Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.98
AMYRIS, INC. completed a disposition involving THG Beauty USA LLC for $20 million (closed 2023-12-28).
- Action
- disposition
- Counterparty
- THG Beauty USA LLC
- Consideration
- $20 million
- Closing
- 2023-12-28
Exact text from the filing
On December 28, 2023, Amyris, Inc. (the “Company”) and THG Beauty USA LLC (“THG”) signed and closed an Asset Purchase Agreement (the “APA”) pursuant to which the Company agreed to sell substantially all of the assets of the Company's clean beauty brand, Biossance ® , to THG for $20 million.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
AMYRIS, INC. entered into Asset Purchase Agreement with THG Beauty USA LLC valued at $20 million (effective 2023-12-28).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- THG Beauty USA LLC
- Value
- $20 million
- Effective
- 2023-12-28
Exact text from the filing
On December 28, 2023, Amyris, Inc. (the “Company”) and THG Beauty USA LLC (“THG”) signed and closed an Asset Purchase Agreement (the “APA”) pursuant to which the Company agreed to sell substantially all of the assets of the Company's clean beauty brand, Biossance ® , to THG for $20 million.
View on SEC.gov
Restructurings & Charges
SEC 8-K Item 2.05/2.06
confidence 0.9
AMYRIS, INC. announced a restructuring with charges of approximately $2.4 million affecting certain consumer brands (approximately 220 employees).
- Type
- restructuring
- Charge
- approximately $2.4 million
- Affected area
- certain consumer brands
- Headcount
- approximately 220 employees
Exact text from the filing
In connection with the sale of certain consumer brands, the Company announced the termination or separation of approximately 220 employees at different dates beginning on December 18, 2023 and continuing through January 2024. The Company previously announced reductions in force in June 2023 and August 2023, which, together with general attrition, is expected to result in reduction in force of approximately 51% from June 2023 to the end of January 2024. In connection with this reduction in force, certain impacted employees will be provided severance benefits, including cash severance payments and reimbursement of medical insurance premiums. In connection with the December 2023 and January 2024 reduction in force, the Company expects to record a one-time charge of approximately $2.4 million related to the reduction in its workforce, consisting primarily of one-time severance payments upon termination of the employees.
View on SEC.gov